Real-world data show TRD costs spike during resistant episodes; Compass’ psilocybin COMP360 delivers durable symptom relief through 26 weeks, potentially easing resource strain.
|Videos|February 3, 2022
Building the Bridge Between Psyche and Soma: 2021 Sigourney Award Winner
Author(s)Jorge Claudio Ulnik, MD, PhD
Psychoanalysis and dermatology: this Sigourney Award Winner is bridging the 2 specialties.
Advertisement
"The recognition of The Sigourney Award-2021 will enable us to break barriers and continue building bridges between psyche and soma that can be crossed by physicians and patients, thus achieving a closer, more humane, and personalized medical practice..."
To read Dr Ulnik's article, please see
Dr Ulnik is a psychiatrist, psychoanalyst (Asociación Psicoanalítica Argentina), president of EULAPS and associate professor of pathophysiology and psychosomatic diseases, and adjunct professor of mental health at the Universidad de Buenos Aires in Argentina.
Advertisement
Related to this article
Antipsychotic levels clarify adherence, guide dose escalation up to a point of futility, and offer more than pharmacogenetic testing, says Jonathan Meyer, MD.
Learn how clinicians tailor antidepressants by diagnosis, symptoms, adverse effects, and next-step strategies for treatment-resistant depression.
How to interpret antipsychotic drug levels in schizophrenia: when labs mislead, when levels help adherence and toxicity checks, and why serial monitoring matters.
Male athletes with anorexia often go unnoticed as “discipline”; learn red flags, sport-specific risks, health consequences, and treatment steps for earlier diagnosis.
Explore major depression subtypes—from melancholic to inflammatory—and how they shape symptoms, biology, and treatment choices for better outcomes.
Therapeutic drug monitoring takes guesswork out of antipsychotic care—spotting nonadherence, guiding dose targets, and defining response thresholds and the “point of futility” in schizophrenia.
A psychiatric NP shares mentorship lessons, training fixes, and her Psych NP Boot Camp—plus practical tips to close prescriber gaps and improve team-based care.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Antipsychotic Plasma Levels in Schizophrenia: Detecting Nonadherence and Guiding Dose Decisions
2
Choosing an Antidepressant: Art, Science, and Knowing Your Patient
3
Can Durable Response to Psilocybin Reshape Treatment-Resistant Depression Care?
4
Responding to Intimate Partner Violence Disclosures in Psychiatry
5